Rexulti 2 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FX4A0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,887
Award facts
- Contract value 100% obligated
- $37,887.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count) under a firm fixed-price contract valued at $37,887.16, with an ultimate completion date of December 23, 2025. This non-set-aside delivery order represents a competitive award to the prime contractor, which maintains its corporate office in Conshohocken, Pennsylvania, the designated place of performance. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, demonstrates significant federal contracting capability through its extensive portfolio of medical product deliveries with the Defense Logistics Agency and its Medical Supply Chain. The company serves critical federal medical procurement needs for military and veteran healthcare systems, with contract awards encompassing a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Rexulti, a prescription psychiatric medication, reflects the company's ongoing role as a key vendor supporting the Defense Health Agency and other government healthcare systems through flexible and comprehensive contract mechanisms.
Quick answers
Who was awarded contract SPE2DR26FX4A0?
SPE2DR26FX4A0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FX4A0 worth?
The government has obligated $37,887 on SPE2DR26FX4A0.
Is contract SPE2DR26FX4A0 an order under another contract?
Yes. SPE2DR26FX4A0 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX4A0 competed?
The extent of competition for SPE2DR26FX4A0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award